P

Inventor

COHEN STANLEY N

US39 patents
⚠️ This page may combine multiple inventors who share the name “COHEN STANLEY N”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV LELAND STANFORD JUNIOR

21 patents
US4237224ADec 2, 1980

Process for producing biologically functional molecular chimeras

UNIV LELAND STANFORD JUNIOR507 citations97
US5679523AOct 21, 1997

Method for concurrent disruption of expression of multiple alleles of mammalian genes

UNIV LELAND STANFORD JUNIOR78 citations96
US4440853AApr 3, 1984

Microbiological methods using hollow fiber membrane reactor

UNIV LELAND STANFORD JUNIOR71 citations96
US4468464AAug 28, 1984

Biologically functional molecular chimeras

UNIV LELAND STANFORD JUNIOR142 citations95
US6835816B2Dec 28, 2004

Mammalian tumor susceptibility genes and their uses

UNIV LELAND STANFORD JUNIOR21 citations92
US6248523B1Jun 19, 2001

Mammalian tumor susceptibility genes and their uses

UNIV LELAND STANFORD JUNIOR19 citations92
US5891668AApr 6, 1999

Mammalian tumor susceptibility genes and their uses

UNIV LELAND STANFORD JUNIOR22 citations92
US5807995ASep 15, 1998

Mammalian tumor susceptibility genes and their uses

UNIV LELAND STANFORD JUNIOR19 citations92
US4374927AFeb 22, 1983

Extrachromosomal regulation of expression

UNIV LELAND STANFORD JUNIOR30 citations92
US4740470AApr 26, 1988

Biologically functional molecular chimeras

UNIV LELAND STANFORD JUNIOR32 citations91
US4495280AJan 22, 1985

Cloned high signal strength promoters

UNIV LELAND STANFORD JUNIOR35 citations87
US7714108B2May 11, 2010

Mammalian tumor susceptibility gene products and their uses

UNIV LELAND STANFORD JUNIOR4 citations63
US10882821B1Jan 5, 2021

Enantiomeric compound for the reduction of the deleterious activity of extended nucleotide repeat containing genes

UNIV LELAND STANFORD JUNIOR1 citations62
US7838252B2Nov 23, 2010

Methods and compositions for treating a subject having an anthrax toxin mediated condition

UNIV LELAND STANFORD JUNIOR3 citations60
US7592154B2Sep 22, 2009

Modulating SOS response induction by antimicrobial agents

UNIV LELAND STANFORD JUNIOR2 citations56
US5607842AMar 4, 1997

Use of tRNA genes to stabilize the inheritance of unstable plasmids in populations of growing cells

UNIV LELAND STANFORD JUNIOR3 citations54
US7973130B2Jul 5, 2011

Mammalian tumor susceptibility genes and their uses

UNIV LELAND STANFORD JUNIOR0 citations52
US10760077B2Sep 1, 2020

Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genes

UNIV LELAND STANFORD JUNIOR0 citations50
US9862947B2Jan 9, 2018

Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genes

UNIV LELAND STANFORD JUNIOR0 citations50
US5422275AJun 6, 1995

Protein production at synthetic start site

UNIV LELAND STANFORD JUNIOR0 citations48
US10675293B2Jun 9, 2020

Nucleoside agents for the reduction of the deleterious activity of extended nucleotide repeat containing genes

UNIV LELAND STANFORD JUNIOR0 citations46

HARVARD COLLEGE

6 patents

CETUS CORP

3 patents

CHENG TZU-HAO

3 patents

UNIV STANFORD

1 patent

LIH CHIH JIAN

1 patent

UNIV NAT YANG MING

1 patent

FUNCTIONAL GENETICS INC

1 patent

NAT YANG-MING UNIV

1 patent

COHEN STANLEY N

1 patent